Global Transcatheter Heart Valve Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Technology;
Ballon Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve.By Application;
Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, and Mammography Transcatheter Mitral Valve.By End User;
Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Transcatheter Heart Valve Market (USD Million), 2021 - 2031
In the year 2024, the Global Transcatheter Heart Valve Market was valued at USD 4,448.23 million. The size of this market is expected to increase to USD 10,820.06 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 13.5%.
The global transcatheter heart valve market has witnessed significant growth over recent years and is poised for further expansion. Transcatheter heart valve replacement (THVR) procedures have emerged as a less invasive alternative to traditional open-heart surgery for patients suffering from valvular heart diseases. This minimally invasive approach offers numerous benefits, including shorter recovery times, reduced hospital stays, and lower risk of complications, driving the demand for transcatheter heart valves.
One of the key factors fueling the growth of the transcatheter heart valve market is the rising prevalence of cardiovascular diseases worldwide. As the aging population increases and lifestyles become increasingly sedentary, the incidence of heart valve disorders such as aortic stenosis and mitral regurgitation is on the rise. This demographic trend, coupled with advances in medical technology and improved patient outcomes, has led to a surge in the adoption of transcatheter heart valve procedures.
Ongoing research and development activities aimed at enhancing the efficacy and safety of transcatheter heart valve products are contributing to market growth. Manufacturers are investing heavily in product innovation to introduce next-generation devices with improved durability, better functionality, and enhanced compatibility with varying anatomies. Additionally, expanding indications for transcatheter heart valve procedures, along with favorable reimbursement policies in many countries, are further driving market expansion.
The transcatheter heart valve market also faces challenges such as stringent regulatory requirements and high procedural costs. Despite these challenges, the market is expected to continue its upward trajectory, fueled by increasing awareness about minimally invasive treatment options among patients and healthcare providers alike. With ongoing technological advancements and a growing emphasis on personalized medicine, the transcatheter heart valve market is poised for continued growth in the coming years.
Global Transcatheter Heart Valve Market Recent Developments
-
In September 2019, Medtronic announced the U.S. launch of the Evolut PRO+, a transcatheter aortic valve replacement (TAVR) system.
-
In September 2019, Abbott commenced the TRILUMINATE pivotal trial to evaluate the TriClip, a transcatheter repair device for treating tricuspid regurgitation.
Segment Analysis
By Technology, the market includes transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair/replacement (TMVR). TAVR dominates due to its effectiveness in treating aortic stenosis in high-risk patients. TMVR is gaining momentum as advancements address complexities in mitral valve conditions, offering minimally invasive solutions for patients unsuitable for open-heart surgery.
By Application, the market serves conditions such as aortic stenosis, mitral regurgitation, and other valvular diseases. Aortic stenosis treatment drives demand, supported by the rising elderly population and improved procedural outcomes. The mitral regurgitation segment is expanding due to innovations in transcatheter repair systems, reflecting unmet needs in managing mitral valve disorders.
By End User, the market is segmented into hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals account for the largest share, benefiting from robust infrastructures and access to advanced technologies. ASCs are rapidly growing as they offer cost-effective, minimally invasive options with reduced recovery times, aligning with patient preferences for outpatient care.
By Geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America leads due to the high adoption of advanced healthcare technologies and supportive reimbursement policies. Europe follows closely, driven by a strong focus on innovative cardiac care solutions. Meanwhile, the Asia-Pacific region is witnessing rapid growth owing to increasing healthcare investments and a rising prevalence of valvular diseases.
Global Transcatheter Heart Valve Segment Analysis
In this report, the Global Transcatheter Heart Valve Market has been segmented by Technology, Application, End User, and Geography.
Global Transcatheter Heart Valve Market, Segmentation by Technology
The Global Transcatheter Heart Valve Market has been segmented by Technology into Ballon Expanded Transcatheter Valve and Self-Expanded Transcatheter Valve.
Ballon Expanded Transcatheter Valve technology utilizes a balloon-`expandable valve system. In this approach, a collapsible heart valve is mounted onto a catheter with a balloon at its tip. During the procedure, the catheter is guided to the site of the diseased valve, where the balloon is inflated to expand the new valve into place. This method allows for precise placement and effective sealing, providing a viable solution for patients with aortic stenosis and other valve-related conditions.
Self-Expanded Transcatheter Valve technology employs a self-expanding mechanism to deploy the valve within the heart. These valves are made of materials that have shape memory properties, allowing them to expand and conform to the native valve anatomy without the need for external inflation. This technology offers advantages in terms of ease of deployment and potentially reduced procedural time, making it a preferred choice for certain patient populations and clinical scenarios.
The choice between these technologies often depends on factors such as patient anatomy, the severity of the valve disease, and the preference and expertise of the treating physician. Both Ballon Expanded and Self-Expanded Transcatheter Valve technologies have demonstrated efficacy and safety in clinical studies, contributing to their widespread adoption in transcatheter heart valve procedures globally. As the field continues to evolve, ongoing research and development efforts aim to further enhance these technologies, driving innovation and improving outcomes for patients with heart valve disease.
Global Transcatheter Heart Valve Market, Segmentation by Application
The Global Transcatheter Heart Valve Market has been segmented by Application into Transcatheter Aortic Valve, Transcatheter Pulmonary Valve and Mammography Transcatheter Mitral Valve.
Transcatheter aortic valve, holds a prominent position in the market. Aortic valve replacement procedures are among the most common cardiac surgeries performed worldwide. Transcatheter aortic valve replacement (TAVR) has emerged as a less invasive alternative to traditional open-heart surgery for patients with aortic valve stenosis. The demand for TAVR procedures is expected to continue rising due to the aging population and the growing adoption of minimally invasive techniques.
Another significant segment is the transcatheter pulmonary valve. Pulmonary valve disease, although less prevalent than aortic valve disease, still presents a substantial medical need, especially among pediatric and congenital heart disease patients. Transcatheter pulmonary valve replacement offers a less invasive treatment option for these patients, providing improved outcomes and reduced recovery times compared to traditional surgical interventions.
A relatively newer but rapidly growing segment is transcatheter mitral valve interventions (TMVI), including mitral valve repair and replacement procedures. Mitral valve disease is common and associated with significant morbidity and mortality. TMVI techniques are evolving rapidly, offering minimally invasive options for patients who may not be suitable candidates for traditional mitral valve surgery. As technology continues to advance and clinical evidence accumulates, the market for transcatheter mitral valve interventions is expected to expand further.
Global Transcatheter Heart Valve Market, Segmentation by End User
The Global Transcatheter Heart Valve Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory, and Others.
Hospitals represent the largest segment, owing to their advanced infrastructure, availability of specialized medical professionals, and capacity to handle complex cases. They are equipped with the necessary resources to perform intricate procedures, making them the primary choice for patients requiring embolization or occlusion treatments.
Ambulatory Surgical Centers (ASCs) are emerging as a significant segment due to their focus on outpatient procedures and minimally invasive techniques. ASCs offer cost-effective solutions, faster recovery times, and streamlined processes, attracting patients seeking efficient and less invasive treatment options.
Cardiac Catheterization Laboratories specialize in procedures involving the cardiovascular system, including embolization treatments for aneurysms or abnormal blood vessel conditions. These labs are crucial in the adoption of advanced transcatheter devices, driven by the growing prevalence of cardiac-related conditions worldwide.
The "Others" category encompasses specialty clinics and other healthcare facilities where transcatheter embolization and occlusion devices may be used. These settings cater to niche or region-specific demands, broadening the accessibility of these critical medical technologies.
Global Transcatheter Heart Valve Market, Segmentation by Geography
In this report, the Global Transcatheter Heart Valve Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Transcatheter Heart Valve Market Share (%), by Geographical Region, 2024
The North American region holds a significant share in the global transcatheter heart valve market. This can be attributed to several factors, including the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and favorable reimbursement policies. Additionally, the presence of key market players and ongoing technological advancements contribute to the growth of this market segment. The United States, in particular, accounts for a substantial portion of the market share due to its robust healthcare system and increasing adoption of minimally invasive procedures.
In Europe, the transcatheter heart valve market is also witnessing considerable growth. Countries like Germany, France, and the United Kingdom are major contributors to this growth due to the rising aging population and increasing awareness about minimally invasive treatment options. Moreover, favorable government initiatives and reimbursement policies further propel market expansion in this region. Continuous efforts by healthcare organizations to improve patient outcomes and reduce hospital stays also drive the demand for transcatheter heart valve procedures in Europe.
The Asia Pacific region is emerging as a lucrative market for transcatheter heart valves, fueled by factors such as the growing geriatric population, increasing prevalence of cardiovascular diseases, and improving healthcare infrastructure. Countries like China, Japan, and India are witnessing rapid adoption of transcatheter heart valve procedures due to rising healthcare expenditure and expanding access to advanced medical technologies. Furthermore, supportive government initiatives to address the burden of cardiovascular diseases contribute to market growth in this region.
In the Middle East and Africa (MEA) and Latin America regions, the transcatheter heart valve market is also experiencing growth, albeit at a comparatively slower pace. Factors such as improving healthcare infrastructure, increasing awareness about minimally invasive procedures, and rising healthcare expenditure contribute to market expansion in these regions. However, challenges such as limited access to healthcare facilities in rural areas and economic constraints may hinder market growth to some extent. Nevertheless, efforts by governments and healthcare organizations to enhance healthcare access and affordability are expected to drive the adoption of transcatheter heart valve procedures in MEA and Latin America.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Transcatheter Heart Valve Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers
- Aging Population
- Technological Advancements
- Rising Cardiovascular Disease Prevalence
-
Increasing Minimally Invasive Procedures: The global transcatheter heart valve market has witnessed significant growth in recent years, primarily fueled by the increasing adoption of minimally invasive procedures. Transcatheter heart valve replacement (TAVR) procedures have emerged as a preferred option for patients with aortic valve stenosis, particularly those deemed high-risk or inoperable for traditional open-heart surgery. This shift towards minimally invasive techniques is attributed to several factors, including shorter recovery times, reduced hospital stays, and lower post-operative complications compared to conventional surgery.
Technological advancements in transcatheter heart valve devices have played a pivotal role in driving market expansion. Innovations such as next-generation valve designs, improved delivery systems, and advanced imaging techniques have enhanced procedural outcomes and expanded the eligible patient population. Additionally, increasing investments in research and development by key market players have resulted in the introduction of novel devices with enhanced safety profiles and improved long-term durability, further driving market growth.
The aging global population and rising prevalence of cardiovascular diseases have contributed to the growing demand for transcatheter heart valve procedures. As the incidence of valvular heart diseases continues to rise, there is a greater need for effective and less invasive treatment options, driving the adoption of transcatheter interventions. With ongoing technological advancements and a favorable regulatory landscape, the transcatheter heart valve market is poised for continued expansion, offering promising prospects for patients and healthcare providers alike.
Restraints
- High Procedure Costs
- Stringent Regulatory Requirements
- Limited Reimbursement Policies
-
Risk of Procedural Complications: The global transcatheter heart valve market has seen substantial growth in recent years, offering a less invasive alternative to traditional open-heart surgery for patients with valvular heart disease. While transcatheter procedures present several advantages, including shorter recovery times and reduced hospital stays, they also carry inherent risks of procedural complications. One significant risk is paravalvular leakage, where the valve fails to seal properly with the surrounding tissue, leading to blood leakage around the implant. This can result in heart failure, necessitating additional procedures or interventions to correct.
Another potential complication is embolization, where debris or tissue dislodges during the procedure and travels to other parts of the body, causing blockages in blood vessels. Embolization can lead to stroke or other serious cardiovascular events, requiring immediate medical attention. Moreover, there's a risk of conduction disturbances, such as arrhythmias or heart block, due to the proximity of the transcatheter valve to the heart's electrical conduction system. These disturbances can affect the heart's rhythm and may require pacemaker implantation or other interventions to manage.
Patient-specific factors can increase the risk of procedural complications, such as older age, frailty, or the presence of other comorbidities like diabetes or kidney disease. Proper patient selection and pre-procedural assessment are crucial in minimizing these risks. Despite the advancements in transcatheter heart valve technology and procedural techniques, healthcare providers must remain vigilant in monitoring patients post-procedure for any signs of complications and providing appropriate management to ensure optimal outcomes.
Opportunities
- Emerging Markets Expansion
- Product Innovation and Development
- Growing Healthcare Expenditure
-
Rising Awareness About Heart Diseases: The global transcatheter heart valve market has witnessed significant growth, driven largely by the rising awareness about heart diseases among the general population. With heart diseases being one of the leading causes of mortality worldwide, there has been a heightened focus on preventive measures, early detection, and innovative treatment options. Transcatheter heart valve procedures offer a minimally invasive alternative to traditional open-heart surgeries, which can be particularly appealing to patients seeking less invasive treatment options. This has contributed to the increasing adoption of transcatheter heart valve procedures, thereby boosting the growth of the market.
Advancements in medical technology and techniques have improved the safety and efficacy of transcatheter heart valve procedures, making them a viable option for a broader range of patients, including those considered high-risk for surgery. As a result, more patients and physicians are opting for transcatheter interventions, further propelling market growth. Additionally, the growing geriatric population, who are at a higher risk of developing heart diseases, is driving demand for transcatheter heart valve procedures. As awareness about the benefits of these procedures continues to spread and technology continues to evolve, the global transcatheter heart valve market is expected to witness sustained growth in the coming years.
Initiatives undertaken by governments and healthcare organizations to promote awareness about heart health and provide access to advanced medical treatments are also contributing to the expansion of the transcatheter heart valve market. Public health campaigns, educational programs, and screening initiatives are helping to identify individuals at risk of heart diseases at an earlier stage, thereby increasing the pool of potential candidates for transcatheter heart valve procedures. This concerted effort to raise awareness and improve access to innovative treatments underscores the importance of addressing cardiovascular health on a global scale and is likely to fuel continued growth in the transcatheter heart valve market.
Competitive Landscape Analysis
Key players in Global Transcatheter Heart Valve Market include:
- Edwards Lifesciences Corporation
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- CryoLife, Inc
- JenaValve Technology, Inc
- Braile Biomédica
- Colibri Heart Valve, LLC
- Venus Medtech (Hangzhou) Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Transcatheter Heart Valve Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population
- Technological Advancements
- Rising Cardiovascular Disease Prevalence
- Increasing Minimally Invasive Procedures
- Restraints
- High Procedure Costs
- Stringent Regulatory Requirements
- Limited Rembursement Policies
- Risk of Procedural Complications
- Opportunities
- Emerging Markets Expansion
- Product Innovation and Development
- Growing Healthcare Expenditure
- Rising Awareness About Heart Diseases
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Transcatheter Heart Valve Market, By Technology, 2021 - 2031 (USD Million)
- Ballon Expanded Transcatheter Valve
- Self-Expanded Transcatheter Valve
- Global Transcatheter Heart Valve Market, By Application, 2021 - 2031 (USD Million)
- Transcatheter Aortic Valve
- Transcatheter Pulmonary Valve
- Mammography Transcatheter Mitral Valve
- Global Transcatheter Heart Valve Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratory
- Others
- Global Transcatheter Heart Valve Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Transcatheter Heart Valve Market, By Technology, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Edwards Lifesciences Corporation
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- CryoLife, Inc
- JenaValve Technology, Inc
- Braile Biomédica
- Colibri Heart Valve, LLC
- Venus Medtech (Hangzhou) Inc
- Company Profiles
- Analyst Views
- Future Outlook of the Market